Related Experiment Video
Updated: Mar 30, 2026

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
Published on: January 1, 2016
Quorum sensing disruption in Enterobacter spp.: unlocking new therapeutic pathways against multidrug-resistant
Kayeen Vadakkan1, Kavya Santhosh Ponnathodi2, Suriyakala Gunasekaran3
1Amala Integrated Medical Research Department (AIMRD), Amala Institute of Medical Sciences (AIMS), Amala Nagar, Thrissur, Kerala, 680555, India. kayeenvadakkan@gmail.com.
Abstract:
Enterobacter spp., members of the ESKAPE group of pathogens, are increasingly recognized for their involvement in nosocomial infections and remarkable adaptability, particularly in hospital settings. This review highlights the intricate quorum-sensing (QS) systems in Enterobacter species, emphasizing both canonical and non-canonical pathways, including the acyl-homoserine lactone-mediated AI-1 system, LuxS-dependent AI-2 systems, and the solo LuxR system. QS systems regulate critical bacterial behaviors, including biofilm formation, antibiotic resistance, and virulence gene expression. Additionally, the role of quorum quenching (QQ) as a potentially effective anti-virulence strategy is also discussed, with a focus on enzymatic and natural-product-based approaches that disrupt bacterial communication. Enzymes, such as lactonases, and synthetic or plant-derived QS inhibitors have been explored for their ability to attenuate pathogenic traits without exerting the selective pressure that typically drives antimicrobial resistance. Despite significant advances in elucidating QS and QQ processes in Enterobacter spp., notable limitations remain in the molecular understanding of species-specific QS control, particularly regarding the AI-3 signalling pathway and its functional significance. This extensive study seeks to promote future investigations into quorum-sensing disruption as a novel anti-virulence approach and its possible therapeutic application.
More Related Videos
07:13Quantification of Violacein in Chromobacterium violaceum and Its Inhibition by Bioactive Compounds
Published on: August 8, 2025
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Bacterial Signaling
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Bacterial Gastroenteritis